VIPR Corp. (VIPV) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 4.42: the stock has moved about 342% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerVIPR Corp. (VIPV) trades at $0.00003. VIPR Corp. operates in the strategic nutraceutical and nutraceutical-related products sector, focusing on personal consumption, apparel, and home applications. Sector: Materials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for VIPV: VIPV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
VIPR Corp. (VIPV) Materials & Commodity Exposure
VIPR Corp., operating in the basic materials sector, focuses on acquiring, developing, and marketing strategic nutraceutical and nutraceutical-related products. Catering to personal consumption, apparel, and home applications, the company faces challenges typical of small, OTC-listed entities in a competitive market.
What Is the Investment Thesis for VIPV?
VIPR Corp. presents a speculative investment opportunity, given its small market capitalization and OTC listing. Key value drivers include successful acquisition and development of marketable nutraceutical products. Growth catalysts hinge on effective marketing strategies and expansion into new application areas within personal consumption, apparel, and home applications. However, potential risks include limited financial resources, intense competition, and the inherent volatility associated with OTC-listed stocks. Investors should carefully consider the company's financial position, market execution, and the regulatory landscape governing nutraceutical products. The company's P/E ratio is -0.01 and the Beta is 4.42 as of March 17, 2026.
Based on FMP financials and quantitative analysis
VIPV Key Highlights
VIPR Corp. focuses on the acquisition, development, and marketing of strategic nutraceutical and nutraceutical related products.
- The company targets applications in personal consumption, apparel, and home applications.
- VIPR Corp. was formerly known as S2C Global Systems Inc. and changed its name in August 2014.
- The company is based in Scottsdale, Arizona.
- VIPR Corp. has a market capitalization of $0.00B as of March 17, 2026.
Who Are VIPV's Competitors?
VIPV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| NEXM NexMetals Mining Corp. | $1.89 | +1.34% | $66.3M | 40 5-pillar |
| ATLX Atlas Lithium Corporation | $2.57 | +6.64% | $75.4M | — |
| NVA Nova Minerals Limited | $6.06 | +5.21% | $98.7M | 50 5-pillar |
| PLG Platinum Group Metals Ltd. | $1.29 | +1.98% | $165M | 46 5-pillar |
| VOXR Vox Royalty Corp. | $5.03 | 0.00% | $347M | 88 5-pillar |
| ITRG Integra Resources Corp. | $2.61 | -1.14% | $535M | 70 5-pillar |
| ALOY Blackboxstocks Inc. Common Stock | $8.11 | -0.12% | $553M | — |
| GROY Gold Royalty Corp. | $2.94 | -1.01% | $679M | 61 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VIPV's Key Strengths?
Focus on a growing market segment (nutraceuticals).
- Potential for product innovation.
- Flexibility to adapt to changing consumer preferences.
What Are VIPV's Weaknesses?
Limited financial resources.
- Small market capitalization.
- OTC listing increases perceived risk.
- Dependence on successful product development and marketing.
What Are the Key Risks for VIPV?
Negative return on equity (-0.0%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Limited financial resources to compete with larger players.
- Changing regulatory landscape for nutraceuticals.
- Intense competition in the nutraceuticals market.
- Low liquidity due to OTC listing.
- Economic downturn affecting consumer spending on discretionary items.
What Are VIPV's Competitive Advantages?
- Proprietary formulations (if any).
- Strategic partnerships (if any).
- Brand recognition (limited, but potential for growth).
- Focus on niche markets within the nutraceutical space.
What Does VIPV Do?
VIPR Corp., based in Scottsdale, Arizona, operates within the basic materials sector, specifically focusing on strategic nutraceutical and nutraceutical-related products. Founded as S2C Global Systems Inc., the company rebranded to VIPR Corp. in August 2014, signaling a strategic shift towards the nutraceutical market. The company's core business revolves around the acquisition, development, and marketing of these products, targeting applications in personal consumption, apparel, and home goods. VIPR Corp. aims to capitalize on the growing consumer interest in health and wellness products. The company's strategy involves identifying and developing nutraceutical products that can be integrated into various consumer goods. Its small size and focus on niche markets differentiate it from larger players in the broader consumer goods and nutraceutical industries. As of 2026, VIPR Corp. continues to navigate the challenges and opportunities presented by the evolving nutraceutical market, seeking to establish a sustainable presence through strategic product development and marketing initiatives.
What Products and Services Does VIPV Offer?
- Acquires strategic nutraceutical products.
- Develops nutraceutical-related products.
- Markets products for personal consumption.
- Markets products for apparel applications.
- Markets products for home applications.
- Focuses on strategic products.
How Does VIPV Make Money?
- Acquire nutraceutical product rights.
- Develop and formulate products.
- Market and sell products through various channels.
- Generate revenue through product sales.
What Industry Does VIPV Operate In?
VIPR Corp. operates in the nutraceuticals market, a segment of the broader dietary supplements industry. This market is characterized by increasing consumer awareness of health and wellness, driving demand for products with perceived health benefits. The industry is competitive, with numerous players ranging from large multinational corporations to smaller, niche-focused companies. VIPR Corp.'s focus on strategic nutraceutical products places it in a segment that requires innovation and effective marketing to stand out. The company's success depends on its ability to identify and capitalize on emerging trends in consumer health and wellness.
Who Are VIPV's Key Customers?
- Individual consumers seeking health and wellness products.
- Apparel manufacturers integrating nutraceuticals into their products.
- Home goods manufacturers incorporating nutraceuticals into their products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
VIPR Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for VIPR Corp. stands at -0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.0%, showing how much profit it generates from its asset base.
Company Profile
VIPR Corp. operates in the Other Precious Metals industry within the Basic Materials sector. It is headquartered in Scottsdale, US. The company is led by CEO Daniel Roth. VIPV has traded publicly since 2005.
VIPV Financials
VIPV Latest News
-
Stocks That Hit 52-Week Highs On Wednesday
· Feb 19, 2020
VIPV Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for VIPV.
Price Targets
Wall Street price target analysis for VIPV.
VIPV MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for VIPV; grades run from A+ (80-100) to F (below 30).
Leadership: Daniel Roth
Managing Director
Daniel Roth serves as the managing director of VIPR Corp., overseeing the company's strategic direction and operations. As managing director, he is responsible for guiding VIPR Corp.'s efforts in the acquisition, development, and marketing of strategic nutraceutical and nutraceutical-related products.
Track Record: Due to limited information, Daniel Roth's specific achievements and strategic decisions at VIPR Corp. cannot be assessed.
VIPV OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for OTCQX or OTCQB. Companies in this tier often have limited or no financial disclosure, and may not meet minimum financial standards. Investing in OTC Other stocks carries significant risks due to the lack of transparency and regulatory oversight compared to stocks listed on major exchanges like the NYSE or NASDAQ. These securities are often considered highly speculative.
- OTC Tier: OTC Other
- Limited or no financial disclosure.
- Low liquidity and high volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Going concern risk.
- Verify the company's registration and legal standing.
- Assess the company's management team and their experience.
- Review any available financial statements, however limited.
- Understand the company's business model and revenue streams.
- Evaluate the competitive landscape and the company's position.
- Assess the potential risks and challenges facing the company.
- Consult with a qualified financial advisor.
- Company has been in operation for several years.
- The company maintains a website and public presence.
- The company has a clear business model.
- The company has a registered address and contact information.
- The company's management team is identifiable.
VIPR Corp. Materials Stock: Key Questions Answered
What do analysts say about VIPV stock?
As of March 17, 2026, there is no available analyst coverage for VIPV stock. Given its OTC listing and small market capitalization, the stock is unlikely to be actively tracked by major research firms. Investors should rely on their own due diligence and risk assessment when considering an investment in VIPV.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial information available for VIPR Corp.
- OTC stocks carry higher risks than exchange-listed stocks.